חיפוש
46 מחקרים תואמים למסננים אלה. מציג 26–46 מתוך 46 מחקרים
| מספר רישום | מחקר | מצב | שלב | גיוס | אתרים / מדינות | שנת התחלה | עודכן לאחרונה | פעולות |
|---|---|---|---|---|---|---|---|---|
| NCT04634240 | Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise re… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 72 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | לא רלוונטי | 4,000יעד | 72 / 2 | 2020 | 24 ביולי 2025 | |
| NCT05102019 | Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardial ischemia in the distribution of the left coro… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 97 מרכזים בסך הכול | מגייס | לא רלוונטי | 380יעד | 97 / 3 | 2022 | 30 בספט׳ 2026 | |
| NCT06297291 | Global Paradise System US Post Approval Study The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 46 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | 1,000יעד | 46 / 1 | 2024 | 16 באוק׳ 2026 | ||
| NCT07069673 | Abbott Cephea Mitral Valve Disease Registry The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of cor… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 24 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | 1,000יעד | 24 / 1 | 2025 | 10 בספט׳ 2026 | ||
| NCT06909565 | Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an adjunct with statin th… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 153 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 4 | 6,000יעד | 153 / 1 | 2025 | 16 בנוב׳ 2026 | |
| NCT05677100 | Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejec… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 50 מרכזים בסך הכול | מגייס | לא רלוונטי | 320יעד | 50 / 2 | 2023 | 25 באוג׳ 2026 | |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 1,142 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 11,800יעד | 1,142 / 51 | 2025 | 12 בנוב׳ 2026 | |
| NCT07798726 | TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System The objective of this clinical trial is to evaluate the safety and effectiveness of the Cephea Mitral Valve System in subjects with symptomatic mitral valve disease (MVD) or are deemed unsuitable for surgery and transcatheter repair. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · פרטי קשר זמינים | מגייס | לא רלוונטי | 565יעד | 1 / 1 | 2026 | 13 בנוב׳ 2026 | |
| NCT07037459 | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fract… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 686 מרכזים בסך הכול | מגייס | שלב 3 | 5,056יעד | 686 / 35 | 2025 | 29 באוק׳ 2026 | |
| NCT07610278 | A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia This is a multicenter, randomized, double-blind, factorial design Phase 2 study to evaluate the pharmacodynamics, safety and tolerability of a combination of QCZ484 and inclisiran compared to QCZ484, inclisiran, and placebo in participants with hypertension and concomitant hypercholesterolemia. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 29 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 | 120יעד | 29 / 1 | 2026 | 30 ביולי 2026 | |
| NCT07567001 | A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to fi… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 838 מרכזים בסך הכול | מגייס | שלב 3 | 5,610יעד | 838 / 27 | 2026 | 18 באוג׳ 2026 | |
| NCT05065216 | Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limit… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 86 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 / שלב 3 | 728יעד | 86 / 10 | 2021 | 14 בספט׳ 2026 | |
| NCT06742723 | A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Hutchinson, Kansas, United States — במרחק 36 ק"מ · 771 מרכזים בסך הכול | מגייס | שלב 3 | 5,000יעד | 771 / 42 | 2025 | 6 בנוב׳ 2026 | |
| NCT06990867 | Optimizing Reperfusion to Improve Outcomes and Neurologic Function The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours. The main question the study aims to answer are: 1. JX10 improves functional outcomes as measured by the modified Rankin… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 104 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 / שלב 3 | 740יעד | 104 / 21 | 2025 | 21 בספט׳ 2026 | |
| NCT05485961 | Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase 2b is a dose-finding study for CSL300 vs placebo. Part 2: Phase 3 aims to assess the efficacy of CSL300 vs placebo on cardiovascular (CV) out… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 566 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 / שלב 3 | 3,110יעד | 566 / 35 | 2024 | 21 בספט׳ 2026 | |
| NCT07662213 | A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s). ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 210 מרכזים בסך הכול | מגייס | שלב 3 | 1,200יעד | 210 / 15 | 2026 | 22 באוק׳ 2026 | |
| NCT07213778 | REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 57 מרכזים בסך הכול | מגייס | שלב 3 | 2,000יעד | 57 / 5 | 2025 | 19 בנוב׳ 2026 | |
| NCT07764978 | Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT This is a randomised, multicentre, controlled, open-label, Phase III global study comparing the efficacy and safety of standard induction regimens (IsaVRd and DRd) followed by AZD0120 versus standard induction regimens followed by continuous therapy (IsaRd and DRd) in participants with newly diagnos… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 124 מרכזים בסך הכול | מגייס | שלב 3 | 750יעד | 124 / 15 | 2026 | 14 באוג׳ 2026 | |
| NCT07654361 | Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination with a reduced-calor… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 71 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 3,600יעד | 71 / 1 | 2026 | 10 באוג׳ 2026 | |
| NCT04566328 | Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell g… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 647 מרכזים בסך הכול | מגייס | שלב 3 | 1,450יעד | 647 / 2 | 2021 | 16 בנוב׳ 2026 | |
| NCT07546929 | HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to cel… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: El Dorado, Kansas, United States — במרחק 85 ק"מ · 25 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 | 300יעד | 25 / 1 | 2023 | 23 באפר׳ 2026 |